Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2327-2021Class II

TheraSphere Administration Set, REF OTT-SPE-FP-226 (990226.SPE)

Boston Scientific Corporation / initiated 2021-07-23 / Open, Classified

Boston Scientific Corporation began a recall of TheraSphere Administration Set, REF OTT-SPE-FP-226 (990226.SPE) on . FDA classified it as Class II and gives the reason as "Potential for leaks and loosening at the patient catheter connection". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2327-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Boston Scientific Corporation
Product
TheraSphere Administration Set, REF OTT-SPE-FP-226 (990226.SPE)
Product code
NAW Microspheres Radionuclide
Reason for recall
Potential for leaks and loosening at the patient catheter connection
FDA root cause
Component change control
Action
The firm disseminated a Medical Device Product Advisory on 07/23/2021 by overnight mail delivery. The letter explained the issue and directed users to ensure a firm connection is made between the outlet luer and the patient catheter prior to, and during ThersSphere administration.
Quantity in commerce
4980 sets
Distribution
Worldwide distribution - US Nationwide and the countries of Belgium, Canada, Germany, Spain, France, United Kingdom/Great Britain, Hong Kong, Ireland, Israel, India, Italy, Netherlands, Poland, Portugal, Saudi Arabia, Singapore, Switzerland, Turkey, and Argentina.
Product codes and lots
GTIN 05060116920253, Lot Numbers: 001E, 002E, 004E, 005E, 006E, 007E, 114E, 690E, 692E

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2327-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2327-2021Class IIOngoingVoluntary: Firm initiated
Z-2328-2021Class IIOngoingVoluntary: Firm initiated